Transforming growth factor-?-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.

1993 • 837 citations

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

1987 • 497 citations

Biologic Therapy of Cancer

1992 • 476 citations

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

1990 • 409 citations

Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions

1985 • 366 citations

Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

1991 • 266 citations

A family of beta 7 integrins on human mucosal lymphocytes.

1992 • 227 citations

ROLE OF THE THYMUS IN IMMUNE REACTIONS IN RATS

1962 • 212 citations

Human transforming growth factor type .beta.2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization

1987 • 204 citations

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.

1992 • 182 citations

Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

1989 • 164 citations

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

1988 • 155 citations

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2

1989 • 153 citations

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.

1990 • 139 citations

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.

1992 • 124 citations

The Transforming Growth Factor‐Betas: A New Family of Immunoregulatory Molecules

1990 • 103 citations

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.

1981 • 100 citations

Differential activation of CD8+ T cells by transforming growth factor-beta 1.

1993 • 77 citations

Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma.

1990 • 71 citations

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth

1983 • 60 citations

Tumor Immunity to Murine Plasma Cell Tumors. I. Tumor-Associated Transplantation Antigens of NZB and BALB/c Plasma Cell Tumors 2 3

1973 • 55 citations

TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.

1989 • 46 citations

Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.

1985 • 46 citations

The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells ?educated? in vitro with MOPC-315 tumor cells

1978 • 42 citations

Oxazaphosphorines as biological response modifiers-experimental and clinical perspectives

1985 • 39 citations

Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.

1991 • 37 citations

Effectiveness of murine leukemia chemotherapy according to the immune state

1977 • 37 citations

Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.

1989 • 36 citations

Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy.

1990 • 33 citations

Distribution of transforming growth factor-β1 in human astrocytomas

1992 • 31 citations

Therapy of the Murine Plasmacytoma MOPC 104E: Role of the Immune Response<xref ref-type="fn" rid="FN2">2</xref>

1978 • 28 citations

Immunomodulation by anticancer drugs

1985 • 20 citations

Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma

1992 • 19 citations

Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival Time

1977 • 19 citations

Involvement of TCR-V beta 8.3+ cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan.

1993 • 18 citations

Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor

1990 • 7 citations

Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers

1991 • 6 citations